Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials.
Agarwal R, Anand S, Eckardt KU, Luo W, Parfrey PS, Sarnak MJ, Solinsky CM, Vargo DL, Winkelmayer WC, Chertow GM.
Am J Nephrol. 2022;53(10):701-710. doi: 10.1159/000528443. Epub 2022 Nov 30.
PMID:36450264
Post-liver-transplant anemia: etiology and management.